{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["RNA-dependent RNA polymerase", "SARS-CoV2", "antiviral", "docking", "protease", "spike receptor-binding domain"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35270131", "DateRevised": {"Year": "2022", "Month": "03", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["663", "10.3390/plants11050663"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "5", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "28"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "<i>Agathis robusta</i> Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches.", "Abstract": {"AbstractText": ["Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2), the causative agent of Coronavirus Disease 2019 (COVID-19), has seriously threatened global health. Alongside the approved vaccines, the discovery of prospective anti-COVID-19 drugs has been progressively targeted. Essential oils (EOs) provide a rich source of compounds with valuable antiviral activities that may contribute as effective agents against COVID-19. In this study, the EO of <i>Agathus robusta</i> bark was investigated for its chemical composition and its antiviral activity against SARS-CoV2. Overall, 26 constituents were identified by gas chromatography-mass spectrometry (GC-MS) analysis. <i>\u03b1</i>-Pinene, tricyclene, <i>\u03b1</i>-terpineol, limonene, <i>d</i>-camphene, <i>trans</i>-pinocarveol, <i>\u03b1</i>-phellandren-8-ol, L-<i>\u03b2</i>-pinene and borneol were the major components. In silico docking of these constituents against viral key enzymes, spike receptor-binding domain (RBD), main protease (Mpro) and RNA-dependent RNA polymerase (RdRp), using Molecular Operating Environment (MOE) software revealed good binding affinities of the components to the active site of the selected targets, especially, the RBD. In Vitro antiviral MTT and cytopathic effect inhibition assays demonstrated a promising anti SARS-CoV2 for <i>A. robusta</i> bark EO, with a significant selectivity index of 17.5. The results suggested using this EO or its individual components for the protection against or treatment of COVID-19."]}, "AuthorList": [{"Identifier": ["0000-0002-1216-8703"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}], "LastName": "Mohamed", "ForeName": "Maged E", "Initials": "ME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt."}], "LastName": "Tawfeek", "ForeName": "Nora", "Initials": "N"}, {"Identifier": ["0000-0001-8658-1296"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt."}], "LastName": "Elbaramawi", "ForeName": "Samar S", "Initials": "SS"}, {"Identifier": ["0000-0002-4434-2075"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt."}], "LastName": "Fikry", "ForeName": "Eman", "Initials": "E"}], "GrantList": [{"GrantID": "NA000159", "Agency": "King Faisal University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565\u2013574. doi: 10.1016/S0140-6736(20)30251-8.", "ArticleIdList": ["10.1016/S0140-6736(20)30251-8", "PMC7159086", "32007145"]}, {"Citation": "de Oliveira O.V., Rocha G.B., Paluch A.S., Costa L.T. Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. J. Biomol. Struct. Dyn. 2021;39:3924\u20133933. doi: 10.1080/07391102.2020.1772885.", "ArticleIdList": ["10.1080/07391102.2020.1772885", "PMC7284156", "32448085"]}, {"Citation": "Wu D., Wu T., Liu Q., Yang Z. The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 2020;94:44\u201348. doi: 10.1016/j.ijid.2020.03.004.", "ArticleIdList": ["10.1016/j.ijid.2020.03.004", "PMC7102543", "32171952"]}, {"Citation": "Ludwig S., Zarbock A. Coronaviruses and SARS-CoV-2: A brief overview. Anesth. Analg. 2020;131:93\u201396. doi: 10.1213/ANE.0000000000004845.", "ArticleIdList": ["10.1213/ANE.0000000000004845", "PMC7173023", "32243297"]}, {"Citation": "Lau S.K., Poon R.W., Wong B.H., Wang M., Huang Y., Xu H., Guo R., Li K.S., Gao K., Chan K.-H. Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup. J. Virol. 2010;84:11385\u201311394. doi: 10.1128/JVI.01121-10.", "ArticleIdList": ["10.1128/JVI.01121-10", "PMC2953156", "20702646"]}, {"Citation": "Valencia D.N. Brief review on COVID-19: The 2020 pandemic caused by SARS-CoV-2. Cureus. 2020;12:e7386. doi: 10.7759/cureus.7386.", "ArticleIdList": ["10.7759/cureus.7386", "PMC7179986", "32337113"]}, {"Citation": "Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020;5:562\u2013569. doi: 10.1038/s41564-020-0688-y.", "ArticleIdList": ["10.1038/s41564-020-0688-y", "PMC7095430", "32094589"]}, {"Citation": "Xu X., Chen P., Wang J., Feng J., Zhou H., Li X., Zhong W., Hao P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. 2020;63:457\u2013460. doi: 10.1007/s11427-020-1637-5.", "ArticleIdList": ["10.1007/s11427-020-1637-5", "PMC7089049", "32009228"]}, {"Citation": "Fehr A.R., Perlman S., editors. Coronaviruses: An Overview of Their Replication and Pathogenesis. Volume 1282. Humana Press; New York, NY, USA: 2015. pp. 1\u201323.", "ArticleIdList": ["PMC4369385", "25720466"]}, {"Citation": "Cui J., Li F., Shi Z.-L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181\u2013192. doi: 10.1038/s41579-018-0118-9.", "ArticleIdList": ["10.1038/s41579-018-0118-9", "PMC7097006", "30531947"]}, {"Citation": "Zhou J., Fang L., Yang Z., Xu S., Lv M., Sun Z., Chen J., Wang D., Gao J., Xiao S. Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach. FASEB J. 2019;33:14575\u201314587. doi: 10.1096/fj.201901624RR.", "ArticleIdList": ["10.1096/fj.201901624RR", "31690127"]}, {"Citation": "Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727\u201311734. doi: 10.1073/pnas.2003138117.", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Zu Z.Y., Jiang M.D., Xu P.P., Chen W., Ni Q.Q., Lu G.M., Zhang L.J. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology. 2020;296:E15\u2013E25. doi: 10.1148/radiol.2020200490.", "ArticleIdList": ["10.1148/radiol.2020200490", "PMC7233368", "32083985"]}, {"Citation": "Rossi G.A., Sacco O., Mancino E., Cristiani L., Midulla F. Differences and similarities between SARS-CoV and SARS-CoV-2: Spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. Infection. 2020;48:665\u2013669. doi: 10.1007/s15010-020-01486-5.", "ArticleIdList": ["10.1007/s15010-020-01486-5", "PMC7393809", "32737833"]}, {"Citation": "Heald-Sargent T., Gallagher T. Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses. 2012;4:557\u2013580. doi: 10.3390/v4040557.", "ArticleIdList": ["10.3390/v4040557", "PMC3347323", "22590686"]}, {"Citation": "Follis K.E., York J., Nunberg J.H. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell\u2013cell fusion but does not affect virion entry. Virology. 2006;350:358\u2013369. doi: 10.1016/j.virol.2006.02.003.", "ArticleIdList": ["10.1016/j.virol.2006.02.003", "PMC7111780", "16519916"]}, {"Citation": "Liu C., Zhou Q., Li Y., Garner L.V., Watkins S.P., Carter L.J., Smoot J., Gregg A.C., Daniels A.D., Jervey S. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Publications; Washington, DC, USA: 2020.", "ArticleIdList": ["32226821"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C. Structure of M pro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q., Ming Z., Zhang L. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779\u2013782. doi: 10.1126/science.abb7498.", "ArticleIdList": ["10.1126/science.abb7498", "PMC7164392", "32277040"]}, {"Citation": "Wang Y., Anirudhan V., Du R., Cui Q., Rong L. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target. J. Med. Virol. 2021;93:300\u2013310. doi: 10.1002/jmv.26264.", "ArticleIdList": ["10.1002/jmv.26264", "32633831"]}, {"Citation": "Allam A.E., Amen Y., Ashour A., Assaf H.K., Hassan H.A., Abdel-Rahman I.M., Sayed A.M., Shimizu K. In silico study of natural compounds from sesame against COVID-19 by targeting M pro, PL pro and RdRp. RSC Adv. 2021;11:22398\u201322408. doi: 10.1039/D1RA03937G.", "ArticleIdList": ["10.1039/D1RA03937G"]}, {"Citation": "Williamson G., Kerimi A. Testing of natural products in clinical trials targeting the SARS-CoV-2 (COVID-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem. Pharmacol. 2020;178:114123. doi: 10.1016/j.bcp.2020.114123.", "ArticleIdList": ["10.1016/j.bcp.2020.114123", "PMC7316054", "32593613"]}, {"Citation": "Ma L., Yao L. Antiviral effects of plant-derived essential oils and their components: An updated review. Molecules. 2020;25:2627. doi: 10.3390/molecules25112627.", "ArticleIdList": ["10.3390/molecules25112627", "PMC7321257", "32516954"]}, {"Citation": "Wink M. Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19. Diversity. 2020;12:175. doi: 10.3390/d12050175.", "ArticleIdList": ["10.3390/d12050175"]}, {"Citation": "Schnitzler P., Astani A., Reichling J. Lipids and Essential Oils. Volume 239 Wiley; Hoboken, NJ, USA: 2011. Antiviral effects of plant-derived essential oils and pure oil components."}, {"Citation": "Asif M., Saleem M., Saadullah M., Yaseen H.S., Al Zarzour R. COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. Inflammopharmacology. 2020;28:1153\u20131161. doi: 10.1007/s10787-020-00744-0.", "ArticleIdList": ["10.1007/s10787-020-00744-0", "PMC7427755", "32803479"]}, {"Citation": "Boland D.J., Brooker M.I.H., Chippendale G., Hall N., Hyland B., Johnston R., Kleinig D., McDonald M., Turner J. Forest Trees of Australia. CSIRO Publishing; Melbourne, Austrilia: 2006."}, {"Citation": "Williams C. Medicinal Plants in Australia Volume 2: Gums, Resins, Tannin and Essential Oils. Volume 2 Rosenberg Publishing; Sydney, Austrilia: 2011."}, {"Citation": "Boysen B.M., Evans M.N., Baker P.J. \u03b4 18O in the Tropical Conifer Agathis robusta Records ENSO-Related Precipitation Variations. PLoS ONE. 2014;9:e102336. doi: 10.1371/journal.pone.0102336.", "ArticleIdList": ["10.1371/journal.pone.0102336", "PMC4111296", "25062034"]}, {"Citation": "Farjon A. A Handbook of the World\u2019s Conifers (2 Vols.) Volume 1 Brill; Leiden, The Netherlands: 2010."}, {"Citation": "Baker R.T., Smith H.G. A Research on the Pines of Australia. WA Gullick, Government Printer; Sydney, Australia: 1910."}, {"Citation": "Smith H.G. Recent Work on the Australian Pines. Vacher & Sons; London, UK: 1911."}, {"Citation": "Brophy J.J., Goldsack R.J., Wu M.Z., Fookes C.J., Forster P.I. The steam volatile oil of Wollemia nobilis and its comparison with other members of the Araucariaceae (Agathis and Araucaria) Biochem. Syst. Ecol. 2000;28:563\u2013578. doi: 10.1016/S0305-1978(99)00090-3.", "ArticleIdList": ["10.1016/S0305-1978(99)00090-3", "10793256"]}, {"Citation": "Verma R.S., Padalia R.C., Goswami P., Verma S.K., Chauhan A., Darokar M.P. Chemical composition and antibacterial activity of the essential oil of Kauri Pine [Agathis robusta (C. Moore ex F. Muell.) FM Bailey] from India. J. Wood Chem. Technol. 2016;36:270\u2013277. doi: 10.1080/02773813.2015.1137946.", "ArticleIdList": ["10.1080/02773813.2015.1137946"]}, {"Citation": "Adams R.P. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry. Volume 456 Allured Publishing Corporation; Carol Stream, IL, USA: 2007."}, {"Citation": "Astani A., Schnitzler P. Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro. Iran. J. Microbiol. 2014;6:149\u2013155.", "ArticleIdList": ["PMC4393490", "25870747"]}, {"Citation": "Astani A., Reichling J., Schnitzler P. Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother. Res. PTR. 2010;24:673\u2013679. doi: 10.1002/ptr.2955.", "ArticleIdList": ["10.1002/ptr.2955", "PMC7167768", "19653195"]}, {"Citation": "Reichling J. Antiviral and Virucidal Properties of Essential Oils and Isolated Compounds\u2014A Scientific Approach. Planta Med. 2021 doi: 10.1055/a-1382-2898.", "ArticleIdList": ["10.1055/a-1382-2898", "34144626"]}, {"Citation": "Sobrinho A.C.N., de Morais S.M., Marinho M.M., de Souza N.V., Lima D.M. Antiviral activity on the Zika virus and larvicidal activity on the Aedes spp. of Lippia alba essential oil and \u03b2-caryophyllene. Ind. Crops Prod. 2021;162:113281. doi: 10.1016/j.indcrop.2021.113281.", "ArticleIdList": ["10.1016/j.indcrop.2021.113281"]}, {"Citation": "Sharma A.D. Eucalyptol (1, 8 cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by molecular docking studies. Preprints. 2020:2020030455. doi: 10.20944/preprints202003.0455.v1.", "ArticleIdList": ["10.20944/preprints202003.0455.v1"]}, {"Citation": "Thuy B.T.P., My T.T.A., Hai N.T.T., Hieu L.T., Hoa T.T., Thi Phuong Loan H., Triet N.T., Anh T.T.V., Quy P.T., Tat P.V. Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega. 2020;5:8312\u20138320. doi: 10.1021/acsomega.0c00772.", "ArticleIdList": ["10.1021/acsomega.0c00772", "PMC7123907", "32363255"]}, {"Citation": "Torres Neto L., Monteiro M.L.G., Galvan D., Conte-Junior C.A. An Evaluation of the Potential of Essential Oils against SARS-CoV-2 from in silico Studies through the Systematic Review Using a Chemometric Approach. Pharmaceuticals. 2021;14:1138. doi: 10.3390/ph14111138.", "ArticleIdList": ["10.3390/ph14111138", "PMC8624289", "34832920"]}, {"Citation": "Mieres-Castro D., Ahmar S., Shabbir R., Mora-Poblete F. Antiviral Activities of Eucalyptus Essential Oils: Their Effectiveness as Therapeutic Targets against Human Viruses. Pharmaceuticals. 2021;14:1210. doi: 10.3390/ph14121210.", "ArticleIdList": ["10.3390/ph14121210", "PMC8706319", "34959612"]}, {"Citation": "Yang Z., Wu N., Zu Y., Fu Y. Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: Effect on nucleocapsid (N) protein. Molecules. 2011;16:1044\u20131054. doi: 10.3390/molecules16021044.", "ArticleIdList": ["10.3390/molecules16021044", "PMC6259611", "21350392"]}, {"Citation": "Meeran M.N., Seenipandi A., Javed H., Sharma C., Hashiesh H.M., Goyal S.N., Jha N.K., Ojha S. Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19? Heliyon. 2021;7:e05703. doi: 10.1016/j.heliyon.2020.e05703.", "ArticleIdList": ["10.1016/j.heliyon.2020.e05703", "PMC7810623", "33490659"]}, {"Citation": "Tshibangu D.S., Matondo A., Lengbiye E.M., Inkoto C.L., Ngoyi E.M., Kabengele C.N., Bongo G.N., Gbolo B.Z., Kilembe J.T., Mwanangombo D.T. Possible effect of aromatic plants and essential oils against COVID-19: Review of their antiviral activity. J. Complement. Altern. Med. Res. 2020;11:10\u201322. doi: 10.9734/jocamr/2020/v11i130175.", "ArticleIdList": ["10.9734/jocamr/2020/v11i130175"]}, {"Citation": "Hachlafi N.E., Aanniz T., Menyiy N.E., Baaboua A.E., Omari N.E., Balahbib A., Shariati M.A., Zengin G., Fikri-Benbrahim K., Bouyahya A. In Vitro and in vivo biological investigations of camphene and its mechanism insights: A review. Food Rev. Int. 2021;37:1\u201328. doi: 10.1080/87559129.2021.1936007.", "ArticleIdList": ["10.1080/87559129.2021.1936007"]}, {"Citation": "Sokolova A., Yarovaya O., Semenova M., Shtro A., Orshanskaya I., Zarubaev V., Salakhutdinov N. Synthesis and In Vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus. Med. Chem. Comm. 2017;8:960\u2013963. doi: 10.1039/C6MD00657D.", "ArticleIdList": ["10.1039/C6MD00657D", "PMC6072209", "30108810"]}, {"Citation": "Sokolova A.S., Kovaleva K.S., Yarovaya O.I., Bormotov N.I., Shishkina L.N., Serova O.A., Sergeev A.A., Agafonov A.P., Maksuytov R.A., Salakhutdinov N.F. (+)-Camphor and (\u2212)-borneol derivatives as potential anti-orthopoxvirus agents. Arch. Pharm. 2021;354:2100038. doi: 10.1002/ardp.202100038.", "ArticleIdList": ["10.1002/ardp.202100038", "33605479"]}, {"Citation": "Verma S., Twilley D., Esmear T., Oosthuizen C.B., Reid A.-M., Nel M., Lall N. Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19) Front. Pharmacol. 2020;11:1514. doi: 10.3389/fphar.2020.561334.", "ArticleIdList": ["10.3389/fphar.2020.561334", "PMC7546787", "33101023"]}, {"Citation": "Indrayanto G., Putra G.S., Suhud F. Validation of in-vitro bioassay methods: Application in herbal drug research. Profiles Drug Subst. Excip. Relat. Methodol. 2021;46:273\u2013307.", "ArticleIdList": ["33461699"]}, {"Citation": "Perveen K., Bokhari N.A., Siddique I., Al-Rashid S.A. Antifungal activity of essential oil of Commiphora molmol Oleo Gum Resin. J. Essent. Oil Bear. Plants. 2018;21:667\u2013673. doi: 10.1080/0972060X.2018.1492975.", "ArticleIdList": ["10.1080/0972060X.2018.1492975"]}, {"Citation": "Bahmanzadegan A., Rowshan V., Saharkhiz M.J. Essential oil composition of Myrtus communis L. under different storage conditions. J. Essent. Oil Bear. Plants. 2015;18:1467\u20131475. doi: 10.1080/0972060X.2014.884767.", "ArticleIdList": ["10.1080/0972060X.2014.884767"]}, {"Citation": "Berka-Zougali B., Ferhat M.-A., Hassani A., Chemat F., Allaf K.S. Comparative study of essential oils extracted from Algerian Myrtus communis L. leaves using microwaves and hydrodistillation. Int. J. Mol. Sci. 2012;13:4673\u20134695. doi: 10.3390/ijms13044673.", "ArticleIdList": ["10.3390/ijms13044673", "PMC3344239", "22606003"]}, {"Citation": "Hendel N., Napoli E., Sarri M., Saija A., Cristani M., Nostro A., Ginestra G., Ruberto G. Essential oil from aerial parts of wild Algerian rosemary: Screening of chemical composition, antimicrobial and antioxidant activities. J. Essent. Oil Bear. Plants. 2019;22:1\u201317. doi: 10.1080/0972060X.2019.1590246.", "ArticleIdList": ["10.1080/0972060X.2019.1590246"]}, {"Citation": "Environment M.O., Chemical Computing Group Inc.  Montreal Quebec Canada.  [(accessed on 2 January 2019)].  Available online:  http://www.chemcomp.com."}, {"Citation": "Wu Y., Wang F., Shen C., Peng W., Li D., Zhao C., Li Z., Li S., Bi Y., Yang Y. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020;368:1274\u20131278. doi: 10.1126/science.abc2241.", "ArticleIdList": ["10.1126/science.abc2241", "PMC7223722", "32404477"]}, {"Citation": "Yin W., Luan X., Li Z., Zhou Z., Wang Q., Gao M., Wang X., Zhou F., Shi J., You E. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin. Nat. Struct. Mol. Biol. 2021;28:319\u2013325. doi: 10.1038/s41594-021-00570-0.", "ArticleIdList": ["10.1038/s41594-021-00570-0", "33674802"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55\u201363. doi: 10.1016/0022-1759(83)90303-4.", "ArticleIdList": ["10.1016/0022-1759(83)90303-4", "6606682"]}, {"Citation": "Mostafa A., Kandeil A., AMM Elshaier Y., Kutkat O., Moatasim Y., Rashad A.A., Shehata M., Gomaa M.R., Mahrous N., Mahmoud S.H. FDA-approved drugs with potent In Vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals. 2020;13:443. doi: 10.3390/ph13120443.", "ArticleIdList": ["10.3390/ph13120443", "PMC7761982", "33291642"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "3"}, {"Year": "2022", "Month": "2", "Day": "20"}, {"Year": "2022", "Month": "2", "Day": "24"}, {"Year": "2022", "Month": "3", "Day": "10", "Hour": "15", "Minute": "37"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["35270131", "PMC8912836", "10.3390/plants11050663", "plants11050663"]}}], "PubmedBookArticle": []}